Home › Stocks › EGRX

EGRX — EAGLE PHARMACEUTICALS IN

Reported value held$68.76M
Funds holding (latest)157
Sector—

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Funds holding (Q2 2026)2
Institutional value$8.28K · 12.35K sh
New / Add / Cut / Exit0 / 0 / 0 / 0 · Updated 2026-11-13
Top-5 / Top-10 concentration100.0% / 100.0%
Institutional holdings change Accumulating +0.0% (+0 sh)
Institutional value change Up +96.5%

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

As of Q2 2026, 2 SEC-registered investment managers reported holding EGRX (EAGLE PHARMACEUTICALS IN) in their latest 13F filings, with a combined reported value of $8.28K across 12.35K shares. That is +0.0% by share count (+0 shares) versus the previous quarter, while reported value moved +96.5%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.

Major shareholders of EAGLE PHARMACEUTICALS IN (EGRX) include ADAGE CAPITAL PARTNERS GP, L.L.C., Balyasny Asset Management, AIGH Capital Management LLC, ranked by reported 13F value among the 157 institutional holders on this page.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q3 2026 2 12.35K $11.73K +0.0%
Q2 2026 2 12.35K $8.28K +0.0%
Q1 2026 2 12.35K $4.21K +0.0%
Q4 2025 2 12.35K $8.64K +0.0%
Q3 2025 2 12.35K $33.34K +0.0%
Q2 2025 2 12.35K $35.81K +0.0%
Q1 2025 2 12.35K $12.10K +0.0%
Q4 2024 8 71.82K $35.83K +16.1%

Over the 8 quarters shown, institutional share counts decreased 83% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2024 (+16.1%).

Top Institutional Holders (Q3 2026) — 2 funds

FundSharesValuePortfolio WeightChange
Stanley-Laman Group, Ltd. 12.00K $11.40K 0.00% Hold
Archer Investment Corp 350 $333 0.00% Hold

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q2 2026 — 2 funds

FundSharesValuePortfolio WeightChange
Stanley-Laman Group, Ltd. 12.00K $8.04K 0.00% Hold
Archer Investment Corp 350 $235 0.00% Hold

Q1 2026 — 2 funds

FundSharesValuePortfolio WeightChange
Stanley-Laman Group, Ltd. 12.00K $4.09K 0.00% Hold
Archer Investment Corp 350 $119 0.00% Hold

Q4 2025 — 2 funds

FundSharesValuePortfolio WeightChange
Stanley-Laman Group, Ltd. 12.00K $8.40K 0.00% Hold
Archer Investment Corp 350 $245 0.00% Hold

Q3 2025 — 2 funds

FundSharesValuePortfolio WeightChange
Stanley-Laman Group, Ltd. 12.00K $32.40K 0.01% Hold
Archer Investment Corp 350 $945 0.00% Hold

Q2 2025 — 2 funds

FundSharesValuePortfolio WeightChange
Stanley-Laman Group, Ltd. 12.00K $34.80K 0.01% Hold
Archer Investment Corp 350 $1.01K 0.00% Hold

View all 157 fund holders →

New Positions (Q2 2026)

No fund opened a new position this quarter.

Fully Exited (vs previous quarter)

No tracked fund fully exited this quarter.

Fund Position History — shares by quarter (top 20 funds)

FundQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Stanley-Laman Group, Ltd. 12.00K 12.00K 12.00K 12.00K 12.00K 12.00K 12.00K 12.00K 12.00K 12.00K 12.00K 12.00K 12.00K — — — — — — —
Archer Investment Corp 350 350 350 350 350 350 350 350 350 350 350 350 350 — — — — — — —
Janus Henderson Group — — — — — — — — — — — 775.52K 1.14M 1.15M 1.15M 1.23M 1.24M 1.44M 1.49M 1.53M
BRANDES INVESTMENT PARTNERS, LP — — — — — — — — — — — 745.08K 1.13M — — — — — — —
Renaissance Technologies — — — — — — — — 256.35K 244.25K 333.85K 294.45K 256.15K 260.47K 208.85K 266.65K 274.28K 252.98K 213.58K 207.78K
Vanguard Group — — — — — — — — 579.51K 564.40K 640.75K 638.12K 643.60K 621.69K 756.73K 763.81K 775.51K 771.76K 780.85K 760.47K
ADAGE CAPITAL PARTNERS GP, L.L.C. — — — — — — — — — — — — 500.00K — — — — — — —
Northern Trust Corp — — — — — — — — 31.95K 94.06K 99.50K 105.97K 97.25K 107.23K 120.75K 118.32K 116.00K 163.10K 140.31K 144.03K
AIGH Capital Management LLC — — — — — — — — 1.21M 1.21M 1.19M — — — — — — — — —
Nantahala Capital Management, LLC — — — — — — — — 1.00M 1.00M 1.26M — — — — — — — — —
Citigroup Inc — — — — — — — — 1.00M 1.00M 2.72K 1.75K 203 6.04K 7.41K 33.78K 58.39K 27.28K 16.11K 35.80K
MILLENNIUM MANAGEMENT LLC — — — — — — — — — 167.78K 257.86K 522.40K 347.53K — — — — — — —
AQR CAPITAL MANAGEMENT LLC — — — — — — — — 374.99K 696.80K 879.07K 493.67K 282.96K — — — — — — —
DIMENSIONAL FUND ADVISORS LP — — — — — — — — — — 171.09K 246.50K 280.69K — — — — — — —
AMERIPRISE FINANCIAL INC — — — — — — — — — — — 25.87K 257.48K — — — — — — —
Geode Capital Management — — — — — — — — 105.85K 108.00K 231.64K 225.29K 219.84K 214.99K 203.15K 200.31K 196.60K 189.85K 205.12K 204.40K
Assenagon Asset Management S.A. — — — — — — — — 183.59K 185.34K 185.34K 217.67K 217.67K — — — — — — —
STATE STREET CORP — — — — — — — — 35.82K 35.82K 213.67K 222.59K 207.77K — — — — — — —
Allspring Global Investments Holdings, LLC — — — — — — — — — — — 3.83K 191.63K — — — — — — —
Morgan Stanley — — — — — — — — 192.21K 300.45K 375.33K 296.86K 164.07K 182.04K 245.81K 250.28K 231.99K 212.31K 147.29K 132.39K

Download holders (CSV)

FAQ

Which funds hold EGRX?

As of 2026-Q2, 2 institutional funds reported holding EGRX (EAGLE PHARMACEUTICALS IN) in SEC 13F filings, with a combined reported value of $8.28K.

How many shares of EGRX do institutions own?

13F filers reported 12.35K shares of EGRX, worth $8.28K in aggregate at the end of 2026-Q2.

Is institutional ownership of EGRX rising or falling?

Share counts moved +0.0% versus the prior quarter — accumulation.

Who are the top institutional holders of EGRX?

The largest 13F holders are ADAGE CAPITAL PARTNERS GP, L.L.C., Balyasny Asset Management, AIGH Capital Management LLC, Janus Henderson Group, BRANDES INVESTMENT PARTNERS, LP; the top 25 are ranked at the top of this page.

Who are the major shareholders of EAGLE PHARMACEUTICALS IN?

The major shareholders of EAGLE PHARMACEUTICALS IN (EGRX) by reported 13F value are ADAGE CAPITAL PARTNERS GP, L.L.C., Balyasny Asset Management, AIGH Capital Management LLC, Janus Henderson Group, BRANDES INVESTMENT PARTNERS, LP, among 157 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own EGRX" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/EGRX/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →